Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors
CH Hennekens - Circulation, 1998 - Am Heart Assoc
Heart Journal. In the inaugural issue of that journal, in October 1925, Dr Conner wrote that
the “newly awakened interest in disorders of the cardiovascular system” has rapidly led to …
the “newly awakened interest in disorders of the cardiovascular system” has rapidly led to …
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
PM Ridker - Annals of internal medicine, 1999 - acpjournals.org
Myocardial infarction often occurs among persons without traditional risk factors, and it has
been hypothesized that assessment of “novel” markers may help identify persons who are …
been hypothesized that assessment of “novel” markers may help identify persons who are …
Endogenous tissue-type plasminogen activator and risk of myocardial infarction
Endogenous tissue-type plasminogen activator (tPA) has been hypothesised to be a marker
of baseline fibrinolytic capacity. We therefore tested whether tPA antigen is associated with …
of baseline fibrinolytic capacity. We therefore tested whether tPA antigen is associated with …
Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
PM Ridker, CH Hennekens, A Cerskus, MJ Stampfer - Circulation, 1994 - Am Heart Assoc
BACKGROUND Plasma levels of D-dimer, the primary degradation product of cross-linked
fibrin, are elevated in several acute thrombotic disorders. However, whether elevated D …
fibrin, are elevated in several acute thrombotic disorders. However, whether elevated D …
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto …
M Cortellaro, C Boschetti, E Cofrancesco… - … and thrombosis: a …, 1992 - Am Heart Assoc
The Progetto Lombardo Atero-Trombosi (PLAT) Study was a prospective, multicenter,
multidisciplinary study of the association among hemostatic variables, conventional risk …
multidisciplinary study of the association among hemostatic variables, conventional risk …
Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors
KL Resch, E Ernst, A Matrai… - Annals of internal …, 1992 - acpjournals.org
▪ Objective: To investigate whether abnormalities in blood viscosity predict a poor prognosis
for subsequent cardiovascular events in stroke survivors.▪ Design: Nested case-control study …
for subsequent cardiovascular events in stroke survivors.▪ Design: Nested case-control study …
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease
AJ Catto, AM Carter, M Stickland… - Thrombosis and …, 1997 - thieme-connect.com
The exact role of the fibrinolytic system in the pathogenesis of stroke remains to be
established. Elevated circulating levels of plasminogen activator inhibitor-1, the principle …
established. Elevated circulating levels of plasminogen activator inhibitor-1, the principle …
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study.
PC Eldwood, A Beswick, JR O'Brien, S Renaud… - Heart, 1993 - heart.bmj.com
OBJECTIVE--To examine the associations between air temperature and risk factors for
ischaemic heart disease. METHOD--Data on risk factors are available from up to 2036 men …
ischaemic heart disease. METHOD--Data on risk factors are available from up to 2036 men …
Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin
GR Upchurch, N Ramdev, MT Walsh… - Journal of thrombosis and …, 1998 - Springer
Oxidant stress leads to covalent oxidative modification of several plasma proteins, chief
among which is fibrinogen. Aspirin can nonenzymatically acetylate fibrinogen's lysine …
among which is fibrinogen. Aspirin can nonenzymatically acetylate fibrinogen's lysine …
Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke.
We evaluated 106 subjects with and 109 subjects without a history of ischemic stroke. All
were attending a metabolic ward. The two groups were compared for major risk factors for …
were attending a metabolic ward. The two groups were compared for major risk factors for …